
Ask a doctor about a prescription for DROPIZOL 10 mg/ml ORAL DROPS IN SOLUTION
Package Leaflet: Information for the Patient
Dropizol 10 mg/ml Oral Drops Solution
Morphine in Opium Tincture
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Package Leaflet
Dropizol is a herbal-based medicine that contains morphine.
Dropizol belongs to a group of medicines called antipropulsives and is used in adults to treat the symptoms of acute diarrhea when the use of other antidiarrheal treatments has not had the sufficient effect.
Dropizol works by inhibiting intestinal motility.
Do not take Dropizol:
Warnings and precautions
Consult your doctor, pharmacist, or nurse before taking Dropizol:
If you experience difficulty urinating, you should contact a healthcare professional.
Dropizol is not recommended before surgery or in the 24 hours following surgery, due to the risk of paralytic ileus, whose symptoms are nausea and vomiting.
Risk of dependence and tolerance with the use of the medicine.
Tolerance, dependence, and addiction.
This medicine contains morphine, which is an opioid medicine. Repeated use of opioids can make the drug less effective (one gets used to it, which is known as tolerance). Repeated use of Dropizol can also cause dependence, abuse, and addiction, which can lead to a potentially fatal overdose. The risk of these side effects may increase with a higher dose and longer duration of use.
Dependence or addiction can make you feel like you no longer have control over the amount of medicine you need to take or how often you need to take it.
The risk of becoming dependent or addicted varies from person to person. You may have a higher risk of becoming dependent or addicted to Dropizol if:
If you notice any of the following signs while taking Dropizol, it could be a sign that you have become dependent or addicted:
If you notice any of these signs, talk to your doctor to discuss the best course of treatment for you, including when it is appropriate to stop and how to do it safely (see section 3, If you stop taking Dropizol).
Children and adolescents
Dropizol should not be used in children and adolescents under 18 years of age.
Acute generalized exanthematous pustulosis (AGEP) has been reported in association with Dropizol treatment. Symptoms usually appear within the first 10 days of treatment. Inform your doctor if you have ever developed a severe skin rash, skin peeling, blisters, and/or mouth sores after taking Dropizol or other opioids. Stop using Dropizol and seek medical attention immediately if you notice any of the following symptoms: blisters, widespread scaly skin, or pus-filled spots along with fever.
Sleep-related breathing disorders
Dropizol may cause sleep-related breathing disorders, such as sleep apnea (pauses in breathing during sleep) and sleep-related hypoxemia (low oxygen level in the blood). Symptoms may include breathing pauses during sleep, nighttime awakenings due to lack of air, difficulty maintaining sleep, or excessive daytime sleepiness. If you or someone else observes these symptoms, contact your doctor. Your doctor may consider a dose reduction.
Contact your doctor if you experience severe upper abdominal pain that may radiate to the back, nausea, vomiting, or fever, as these may be symptoms associated with pancreatitis and biliary tract disease.
Using Dropizol with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
It is especially important that you tell your doctor or pharmacist if you are taking any of the following medicines:
The simultaneous administration of morphine may increase the effects of medicines that reduce blood pressure or other medicines that have an effect on blood pressure.
Using Dropizol with food, drinks, and alcohol
Dropizol can be taken with food and drinks. Dropizol contains alcohol, so caution should be exercised if alcohol is consumed.
See the section below Dropizol contains ethanol.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy:
Dropizol should not be used during pregnancy unless your doctor has told you to do so. Caution should be exercised when using this medicine in pregnant women. Dropizol should not be used near the delivery date due to the risk of withdrawal symptoms in the newborn.
Breastfeeding:
Dropizol should not be used during breastfeeding.
Fertility
It is not known whether morphine may negatively affect fertility. Men and women of childbearing age should use effective contraceptive methods during treatment with Dropizol.
Driving and using machines
Dropizol contains morphine and ethanol and may cause drowsiness and significantly affect your ability to drive or use machines.
Do not drive after taking medicines until you know how they affect you.
Dropizol contains ethanol
This medicine contains 33% ethanol by volume (alcohol); which corresponds to an amount of 260 mg per dose, equivalent to 6.6 ml of beer or 2.8 ml of wine per dose. This medicine is harmful to people with alcoholism. The alcohol content should be taken into account in pregnant or breastfeeding women, children, and high-risk groups, such as patients with liver disease or epilepsy.
Follow exactly the administration instructions of this medicine given by your doctor. If you are in doubt, consult your doctor or pharmacist again.
The recommended dose in adults is:
Adults: 5-10 drops 2-3 times a day.
The single dose should not exceed 1 ml, and the total daily dose should not exceed 6 ml.
Elderly patients: the initial dose should be reduced.
Liver failure: Dropizol should not be used, or the dose should be reduced. See the section Do not take Dropizol and Warnings and precautionsin section 2.
Kidney failure: Dropizol should not be used, or the dose should be reduced. See the section Do not take Dropizol and Warnings and precautionsin section 2.
Each milliliter contains approximately 20 drops.
Method of administration:
Oral route.
Dropizol can be used undiluted or mixed with a glass of water. After mixing with water, it should be taken immediately. If Dropizol is used undiluted, the correct dose can be administered with a spoon.


Press down and turn. and drop onto a spoon or a glass.
Use in children and adolescents
Dropizol should not be used in children and adolescents under 18 years of age.
If you take more Dropizol than you should
If you take too much Dropizol, you may experience constricted pupils, reduced heart rate, low blood pressure, pulmonary edema, breathing difficulties, and reduced level of consciousness, which could lead to coma.
Call your doctor if you have taken more Dropizol than prescribed or if you take it as indicated in the package leaflet and feel uncomfortable.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 915 620 420, indicating the medicine and the amount ingested.
If you forget to take Dropizol
You should take the missed dose as soon as possible, unless it is almost time for the next dose. Do not take a double dose to make up for forgotten doses.
If you stop taking Dropizol
Keep taking the medicine for the time your doctor has told you.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. Stop using Dropizol and seek immediate medical attention if you notice any of the following symptoms.
Severe Adverse Effects
Frequent(may affect up to 1 in 10 people):
Difficulty urinating
Infrequent(may affect up to 1 in 100 people):
Shortness of breath, fatigue, anxiety, bluish discoloration of the lips and fingers and toes, headaches, confusion, convulsions, and swelling of the legs and feet (respiratory depression).
Cardiac arrhythmia (rapid or slow heart rate)
Other Adverse Effects
Very Frequent(may affect more than 1 in 10 people):
Drowsiness and constipation, dry mouth
Frequent(may affect up to 1 in 10 people):
Dizziness, headache, pupil constriction, nausea and vomiting, loss of appetite, indigestion or discomfort, alterations in taste and smell, hives, sweating, bronchospasm, decreased cough, asthenia
Infrequent(may affect up to 1 in 100 people):
Facial flushing, itching, spasms in the lower urinary tract, alteration in liver function tests
Rare(may affect up to 1 in 1,000 people):
Increased concentration of liver enzymes (observed in a blood test) and pancreatitis, pain due to the presence of kidney stones (renal colic) or gallstones (biliary colic), withdrawal symptoms, orthostatic hypotension (a type of hypotension that occurs when standing up, having been seated or lying down)
Very Rare(may affect up to 1 in 10,000 people):
Respiratory difficulty, muscle cramps, convulsions, burning and itching, increased sensitivity to pain, blurred vision, double vision, involuntary eye movement, a disease in which the intestine does not function properly (ileus), abdominal pain, rash, swelling of the hands, ankles, or feet, general malaise, chills, syndrome of inappropriate antidiuretic hormone secretion (SIADH) (symptoms: nausea, general malaise, headache, exhaustion, and in severe cases, may progress to convulsions and coma), amenorrhea.
Unknown Frequency(cannot be estimated from available data):
Adrenal insufficiency (fatigue, weight loss, fainting, hypoglycemia, nausea, diarrhea, vomiting, and abdominal pain), euphoria (strong feeling of well-being, happiness, and excitement), uncontrolled muscle movements, addiction, dysphoric state (sadness, lack of energy), restlessness, decreased libido or potency, hallucinations, vertigo, and fever. Severe skin reaction with blisters, scaly skin, pus-filled spots, and fever. This could be a condition called acute generalized exanthematous pustulosis (AGEP). Sleep apnea (pauses in breathing during sleep). Symptoms associated with pancreatitis and biliary tract inflammation, e.g., severe pain in the upper abdomen that may radiate to the back, nausea, vomiting, or fever.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines www.notificaRAM.es.
By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiration date shown on the box and bottle. The expiration date is the last day of the month indicated.
Do not refrigerate or freeze.
The bottle must be used within 4 weeks after the first opening.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy or any other system for collecting medicinal waste. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Dropizol
Each milliliter of oral solution contains 1 ml of Papaver somniferum(L.), Succus siccus(pure opium) tincture, which is equivalent to 10 mg of morphine.
Each drop contains 50 mg of opium tincture, which is equivalent to 0.5 mg (10 mg/ml) of anhydrous morphine.
Each milliliter contains 20 drops.
Appearance of the Product and Package Contents
Dropizol is a dark brown-red liquid. It is available in a brown glass bottle with a dropper and child-resistant closure.
Presentation: 1 × 10 ml, 2 × 10 ml, 3 × 10 ml, 4 × 10 ml, 5 × 10 ml, and 10 × 10 ml.
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Pharmanovia A/S
Ørestads Boulevard 108, 5
DK-2300 Copenhagen S
Denmark
Email: [email protected]
Manufacturer
Lomapharm GmbH
Langes Feld 5
D-31860 Emmerthal
Germany
Atnahs Pharma Denmark ApS
Copenhagen Towers,
Ørestads Boulevard 108, 5.tv,
DK-2300 Copenhagen S,
Denmark
You can request more information about this medicine by contacting the local representative of the Marketing Authorization Holder:
Denmark Pharmanovia A/S Ørestads Boulevard 108 DK-2300 Copenhagen S Denmark | Norway Pharmanovia A/S Ørestads Boulevard 108 DK-2300 Copenhagen S Denmark |
Iceland Pharmanovia A/S Ørestads Boulevard 108 DK-2300 Copenhagen S Denmark | Finland Pharmanovia A/S Ørestads Boulevard 108 DK-2300 Copenhagen S Denmark |
Sweden Pharmanovia A/S Ørestads Boulevard 108 DK-2300 Copenhagen S Denmark | UK Pharmanovia A/S Ørestads Boulevard 108 DK-2300 Copenhagen S Denmark |
Austria Pharmanovia A/S Ørestads Boulevard 108 DK-2300 Copenhagen S Denmark | Belgium Pharmanovia A/S Ørestads Boulevard 108 DK-2300 Copenhagen S Denmark |
Czech Republic Pharmanovia A/S Ørestads Boulevard 108 DK-2300 Copenhagen S Denmark | Germany Pharmanovia A/S Ørestads Boulevard 108 DK-2300 Copenhagen S Denmark |
Spain Pharmanovia A/S Ørestads Boulevard 108 DK-2300 Copenhagen S Denmark | France Pharmanovia A/S Ørestads Boulevard 108 DK-2300 Copenhagen S Denmark |
Hungary Pharmanovia A/S Ørestads Boulevard 108 DK-2300 Copenhagen S Denmark | Ireland Pharmanovia A/S Ørestads Boulevard 108 DK-2300 Copenhagen S Denmark |
Italy Pharmanovia A/S Ørestads Boulevard 108 DK-2300 Copenhagen S Denmark | Luxembourg Pharmanovia A/S Ørestads Boulevard 108 DK-2300 Copenhagen S Denmark |
Netherlands Pharmanovia A/S Ørestads Boulevard 108 DK-2300 Copenhagen S Denmark | Portugal Pharmanovia A/S Ørestads Boulevard 108 DK-2300 Copenhagen S Denmark |
Romania Pharmanovia A/S Ørestads Boulevard 108 DK-2300 Copenhagen S Denmark | Slovak Republic Pharmanovia A/S Ørestads Boulevard 108 DK-2300 Copenhagen S Denmark |
This medicine is authorized in the Member States of the European Economic Area under the following names:
Denmark: Dropizol
Iceland: Dropizol
Finland: Dropizol
Norway: Dropizol
Sweden: Dropizol
UK: Dropizol
Austria: Dropizol
Belgium: Dropizole
Czech Republic: Dropizol
Germany: Dropizol
Spain: Dropizol
France: Dropizal
Hungary: Dropizol
Ireland: Dropizol
Italy: Dropizole
Luxembourg: Dropizol
Netherlands: Dropizol
Portugal: Dropizale
Romania: Dropizol
Slovak Republic: Dropizol
Date of the last revision of this prospectus:June 2024.
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for DROPIZOL 10 mg/ml ORAL DROPS IN SOLUTION – subject to medical assessment and local rules.